These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7865123)

  • 21. [Isolation of a recombinant strain of vaccinia virus containing the pre S2 region of the viral hepatis B surface antigen in its virion].
    Loparev VN; Mitina IV; Araslanov RR; Ivanova ON; Cheliapov NV; Lotte VD; Chernos VI
    Dokl Akad Nauk SSSR; 1989; 306(5):1250-2. PubMed ID: 2791867
    [No Abstract]   [Full Text] [Related]  

  • 22. [New technology of vaccine production--international prospect of the development. Method and theory of production of vaccines by genetic engineering. a. Vaccinia vector vaccine].
    Hashizume S; Morita M; Takahashi F
    Nihon Rinsho; 1987 Oct; 45(10):2333-41. PubMed ID: 3482288
    [No Abstract]   [Full Text] [Related]  

  • 23. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of the antigenicity and immunogenicity of a new hepatitis B vaccine using a panel of monoclonal antibodies.
    Waters JA; Bailey C; Love C; Thomas HC
    J Med Virol; 1998 Jan; 54(1):1-6. PubMed ID: 9443102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Construction of recombinant adeno-associated virus carrying hepatitis B surface antigen gene and preliminary study of the gene expression and function].
    Hu GF; Wu XB; Yu SY; Dong XY; Chen Q; Hou YD
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jun; 23(6):553-6. PubMed ID: 12810373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Construction of mucosal vaccine derived from HBV surface antigen epitope A and the assay of its immunogenicity].
    Liu X; Yang G; Qiu B; Tian P
    Wei Sheng Wu Xue Bao; 2001 Oct; 41(5):625-9. PubMed ID: 12552813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
    NAM JH; BANG HS; CHO HW; CHUNG YH
    Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live recombinant vaccines using genetically engineered vaccinia virus.
    Paoletti E; Perkus ME; Piccini A
    Antiviral Res; 1985; Suppl 1():301-7. PubMed ID: 3866514
    [No Abstract]   [Full Text] [Related]  

  • 29. Adenovirus vectored vaccines.
    Natuk RJ; Davis AR; Chanda PK; Lubeck MD; Chengalvala M; Murthy SC; Wade MS; Dheer SK; Bhat BM; Murthy KK
    Dev Biol Stand; 1994; 82():71-7. PubMed ID: 7958485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccinia virus: a novel approach for molecular engineering of peptide vaccines.
    Hruby DE
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):35-43; discussion 44. PubMed ID: 8303309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.
    Zheng X; Weinberger KM; Gehrke R; Isogawa M; Hilken G; Kemper T; Xu Y; Yang D; Jilg W; Roggendorf M; Lu M
    Virology; 2004 Nov; 329(2):454-64. PubMed ID: 15518823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presentation of the hydrophilic domains of hepatitis C viral E2 envelope glycoprotein on hepatitis B surface antigen particles.
    Lee IH; Kim CH; Ryu WS
    J Med Virol; 1996 Oct; 50(2):145-51. PubMed ID: 8915880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7.
    Tan GH; Yusoff K; Seow HF; Tan WS
    J Med Virol; 2005 Dec; 77(4):475-80. PubMed ID: 16254965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles.
    Puaux AL; Marsac D; Prost S; Singh MK; Earl P; Moss B; Le Grand R; Riviere Y; Michel ML
    Vaccine; 2004 Sep; 22(27-28):3535-45. PubMed ID: 15315833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
    Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
    Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically engineered poxviruses: a novel approach to the construction of live vaccines.
    Paoletti E; Weinberg RL; Davis SW; Davis M
    Vaccine; 1984 Sep; 2(3):204-8. PubMed ID: 6099648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.